News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,126 Results
Type
Article (16050)
Company Profile (103)
Press Release (292966)
Multimedia
Podcasts (77)
Webinars (18)
Section
Business (95180)
Career Advice (504)
Deals (16391)
Drug Delivery (90)
Drug Development (43994)
Employer Resources (59)
FDA (7499)
Job Trends (6810)
News (166547)
Policy (15611)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (507)
Accelerated approval (28)
Adcomms (13)
Allergies (103)
Alliances (24196)
ALS (85)
Alzheimer's disease (732)
Antibody-drug conjugate (ADC) (194)
Approvals (7865)
Artificial intelligence (296)
Autoimmune disease (115)
Automation (21)
Bankruptcy (158)
Best Places to Work (4931)
BIOSECURE Act (10)
Biosimilars (156)
Biotechnology (40)
Bladder cancer (100)
Brain cancer (43)
Breast cancer (308)
Cancer (2476)
Cardiovascular disease (240)
Career advice (450)
Career pathing (17)
CAR-T (120)
CDC (10)
Cell therapy (329)
Cervical cancer (22)
Clinical research (39835)
Collaboration (1032)
Company closure (1)
Compensation (464)
Complete response letters (56)
COVID-19 (952)
CRISPR (57)
C-suite (827)
Cystic fibrosis (65)
Data (3521)
Decentralized trials (1)
Denatured (19)
Depression (97)
Dermatology (36)
Diabetes (222)
Diagnostics (1859)
Digital health (15)
Diversity (3)
Diversity, equity & inclusion (19)
Drug discovery (157)
Drug pricing (127)
Drug shortages (16)
Duchenne muscular dystrophy (134)
Earnings (38730)
Editorial (28)
Employer branding (5)
Employer resources (55)
Events (44323)
Executive appointments (790)
FDA (9439)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (10)
Funding (759)
Gene editing (109)
Generative AI (27)
Gene therapy (297)
GLP-1 (538)
Government (1602)
Grass and pollen (4)
Guidances (211)
Healthcare (4429)
HIV (22)
Huntington's disease (23)
IgA nephropathy (54)
Immunology and inflammation (105)
Immuno-oncology (38)
Indications (116)
Infectious disease (1069)
Inflammatory bowel disease (99)
Inflation Reduction Act (9)
Influenza (40)
Intellectual property (151)
Interviews (63)
IPO (6602)
IRA (33)
Job creations (2101)
Job search strategy (394)
JPM (35)
Kidney cancer (14)
Labor market (36)
Layoffs (248)
Leadership (14)
Legal (3547)
Liver cancer (42)
Longevity (10)
Lung cancer (330)
Lymphoma (230)
Machine learning (18)
Management (21)
Manufacturing (603)
MASH (117)
Medical device (2566)
Medtech (2601)
Mergers & acquisitions (10351)
Metabolic disorders (680)
mRNA (91)
Multiple sclerosis (82)
NASH (17)
Neurodegenerative disease (177)
Neuropsychiatric disorders (56)
Neuroscience (1444)
Neurotech (1)
NextGen: Class of 2026 (1723)
Non-profit (758)
Now hiring (23)
Obesity (322)
Opinion (178)
Ovarian cancer (108)
Pain (151)
Pancreatic cancer (120)
Parkinson's disease (141)
Partnered (12)
Patents (304)
Patient recruitment (310)
Peanut (22)
People (32842)
Pharmaceutical (61)
Pharmacy benefit managers (19)
Phase 1 (9661)
Phase 2 (16399)
Phase 3 (16496)
Pipeline (4575)
Policy (161)
Postmarket research (1506)
Preclinical (3702)
Press Release (28)
Prostate cancer (159)
Psychedelics (28)
Radiopharmaceuticals (170)
Rare diseases (607)
Real estate (2745)
Recruiting (21)
Regulatory (13249)
Reports (20)
Research institute (667)
Resumes & cover letters (62)
Rett syndrome (27)
RNA editing (8)
RSV (30)
Schizophrenia (109)
Series A (143)
Series B (100)
Service/supplier (2)
Sickle cell disease (60)
Special edition (11)
Spinal muscular atrophy (108)
Sponsored (12)
Startups (1725)
State (2)
Stomach cancer (7)
Supply chain (64)
Tariffs (71)
The Weekly (56)
Vaccines (381)
Venture capital (50)
Weight loss (191)
Women's health (61)
Worklife (4)
Date
Today (15)
Last 7 days (305)
Last 30 days (1490)
Last 365 days (13786)
2026 (5929)
2025 (13986)
2024 (15494)
2023 (17149)
2022 (22367)
2021 (23155)
2020 (21526)
2019 (16580)
2018 (13010)
2017 (15297)
2016 (14281)
2015 (16845)
2014 (13267)
2013 (11189)
2012 (11989)
2011 (12492)
2010 (11404)
Location
Africa (335)
Alabama (28)
Alaska (2)
Arizona (95)
Arkansas (4)
Asia (23343)
Australia (3184)
California (5295)
Canada (2032)
China (807)
Colorado (254)
Connecticut (213)
Delaware (190)
Europe (46434)
Florida (875)
Georgia (135)
Hawaii (1)
Idaho (10)
Illinois (514)
India (67)
Indiana (304)
Iowa (6)
Japan (346)
Kansas (87)
Kentucky (25)
Louisiana (9)
Maine (10)
Maryland (593)
Massachusetts (3981)
Michigan (74)
Minnesota (304)
Mississippi (1)
Missouri (58)
Montana (12)
Nebraska (10)
Nevada (28)
New Hampshire (25)
New Jersey (2003)
New Mexico (7)
New York (1543)
North Carolina (886)
North Dakota (3)
Northern California (2701)
Ohio (120)
Oklahoma (7)
Oregon (21)
Pennsylvania (1199)
Puerto Rico (17)
Rhode Island (20)
South America (519)
South Carolina (17)
South Dakota (1)
Southern California (2104)
Tennessee (89)
Texas (708)
United States (19871)
Utah (120)
Virginia (214)
Washington D.C. (43)
Washington State (354)
West Virginia (3)
Wisconsin (68)
Wyoming (2)
309,126 Results for "pivot pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout
After delaying a late-stage readout last year due to “irregularities” at certain study sites, pivotal data for Bristol Myers Squibb’s Cobenfy appear set to arrive later this year.
April 30, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA Approval
March 11, 2026
·
9 min read
Press Releases
Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia
May 6, 2026
·
9 min read
Press Releases
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
May 18, 2026
·
4 min read
Press Releases
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
March 25, 2026
·
8 min read
Press Releases
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
March 24, 2026
·
7 min read
Press Releases
BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia
May 21, 2026
·
10 min read
Press Releases
2026 ASCO | Pivotal Data of InnoCare’s Novel BCL2 Inhibitor Mesutoclax Released
May 24, 2026
·
4 min read
Press Releases
SONOMOTION BREAK WAVE™ LITHOTRIPSY DEVICE MEETS PIVOTAL TRIAL PRIMARY ENDPOINTS
May 14, 2026
·
3 min read
Press Releases
Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting
May 18, 2026
·
5 min read
1 of 30,913
Next
